Using the Oncotype DX Genomic Prostate Score to Decide if You Are A Candidate for Active Surveillance
Listen now
Description
Anson Tharayanil describes the Oncotype DX Genomic Prostate Score test for men who are diagnosed with low and moderate risk prostate cancer - it is a tool to help them decide if Active Surveillance would be a good treatment decision.
More Episodes
NBA superstar Grant Hill, also an Atlanta Hawks co-owner, and African American health advocate, has teamed up with Dendreon to combat the prostate cancer racial disparities experienced by African American men. He discusses, along with Cancer ABCs CEO Joel Nowak, how men, particularly African...
Published 06/09/22
Published 06/09/22
Overall survival and cancer-specific survival for those with node-positive prostate cancer treated with surgery lived longer than those who elected radiation treatment.
Men diagnosed with node positive prostate cancer need to decide if they want to include a targeted treatment to their...
Published 03/21/22
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
